New York corporate partner Philip Richter was featured as "Dealmaker of the Week" by Am Law Daily for his role in the US$2.9b acquisition of Abraxis BioScience by Celgene Corporation. Mr. Richter represented longtime client Abraxis in the transaction and successfully structured a complex contingent value right (CVR) agreement to align the interests of both parties. Abraxis general counsel Charles Kim said that Mr. Richter "fights hard for his clients and is an incredible business advisor. That's why we've relied on him all these years." To read the full article, please click here.